Vident Investment Advisory’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-9,716
Closed -$254K – 1309
2022
Q1
$254K Sell
9,716
-9,077
-48% -$242K 0.01% 1110
2021
Q4
$534K Buy
18,793
+997
+6% +$31K 0.01% 904
2021
Q3
$568K Buy
+17,796
New +$597K 0.02% 844
2021
Q1
– Sell
-49,583
Closed -$1.52M – 998
2020
Q4
$1.52M Buy
+49,583
New +$1.51M 0.06% 398
2020
Q2
– Sell
-15,581
Closed -$349K – 856
2020
Q1
$349K Sell
15,581
-3,740
-19% -$102K 0.02% 652
2019
Q4
$569K Buy
+19,321
New +$525K 0.04% 511

Other funds holding ELAN

Vident Investment Advisory's ELAN Position: Q2 2022 in Review

Vident Investment Advisory sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 9,716 shares — an estimated $254K sold.

Vident Investment Advisory first reported a position in ELAN in Q4 2019 and held it in 6 quarters. The position peaked at $1.52M in Q4 2020. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • Vident Investment Advisory reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 9,716 Elanco Animal Health shares in Q2 2022, an estimated $254K.
  • Vident Investment Advisory first reported a position in Elanco Animal Health in Q4 2019 and held it in 6 quarters.
  • Vident Investment Advisory's Elanco Animal Health position peaked at $1.52M in Q4 2020.
  • 438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.